BR112013012833A2 - composições farmacêuticas - Google Patents
composições farmacêuticasInfo
- Publication number
- BR112013012833A2 BR112013012833A2 BR112013012833A BR112013012833A BR112013012833A2 BR 112013012833 A2 BR112013012833 A2 BR 112013012833A2 BR 112013012833 A BR112013012833 A BR 112013012833A BR 112013012833 A BR112013012833 A BR 112013012833A BR 112013012833 A2 BR112013012833 A2 BR 112013012833A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41680710P | 2010-11-24 | 2010-11-24 | |
| PCT/US2011/061643 WO2012071324A2 (en) | 2010-11-24 | 2011-11-21 | Pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112013012833A2 true BR112013012833A2 (pt) | 2016-08-23 |
| BR112013012833A8 BR112013012833A8 (pt) | 2018-01-02 |
Family
ID=46146374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013012833A BR112013012833A8 (pt) | 2010-11-24 | 2011-11-21 | Composição farmacêautica e uso de um agente antimicrobiano de oxazolidinona |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20140088164A1 (pt) |
| EP (1) | EP2642996B1 (pt) |
| JP (2) | JP6370550B2 (pt) |
| KR (1) | KR101944124B1 (pt) |
| CN (1) | CN103391778B (pt) |
| AU (1) | AU2011332031B2 (pt) |
| BR (1) | BR112013012833A8 (pt) |
| CA (1) | CA2818249C (pt) |
| EA (1) | EA027791B1 (pt) |
| ES (1) | ES2836809T3 (pt) |
| HU (1) | HUE052801T2 (pt) |
| IL (1) | IL226378A0 (pt) |
| MX (1) | MX350565B (pt) |
| MY (2) | MY182136A (pt) |
| NZ (1) | NZ610638A (pt) |
| PT (1) | PT2642996T (pt) |
| SG (2) | SG190354A1 (pt) |
| UA (1) | UA113722C2 (pt) |
| WO (1) | WO2012071324A2 (pt) |
| ZA (1) | ZA201303732B (pt) |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| US5895663A (en) | 1997-07-31 | 1999-04-20 | L. Perrigo Company | Pseudoephedrine hydrochloride extended-release tablets |
| US6451345B1 (en) * | 2000-01-20 | 2002-09-17 | Eurand Pharmaceuticals Ltd. | Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration |
| US20010053791A1 (en) | 2000-03-16 | 2001-12-20 | Babcock Walter C. | Glycogen phosphorylase inhibitor |
| PE20011088A1 (es) * | 2000-03-22 | 2001-10-04 | Upjohn Co | Tratamiento de infecciones del tracto urinario con oxazolidinonas antibacterianas |
| PL201686B1 (pl) | 2000-03-22 | 2009-04-30 | Upjohn Co | Sprasowana tabletka i zastosowanie linezolidu oraz substancji pomocniczych do wytwarzania sprasowanej tabletki |
| EP1289984A4 (en) | 2000-06-05 | 2004-11-24 | Dong A Pharm Co Ltd | NEW OXAZOLIDE DERIVATIVES AND A METHOD FOR THEIR PRODUCTION |
| JP4969013B2 (ja) * | 2000-06-21 | 2012-07-04 | キュービスト ファーマスーティカルズ インコーポレイテッド | 抗菌剤の経口吸収を改善するための組成物および方法 |
| HUP0401811A2 (hu) | 2000-12-11 | 2004-12-28 | Takeda Chemical Industries, Ltd. | Javított vízoldékonyságú gyógyszerkészítmény és eljárás az előállítására |
| JP2002241268A (ja) * | 2000-12-11 | 2002-08-28 | Takeda Chem Ind Ltd | 水溶解性が改善された医薬組成物 |
| AU2004267007C1 (en) | 2003-06-03 | 2010-04-29 | Melinta Subsidiary Corp. | Biaryl heterocyclic compounds and methods of making and using the same |
| EP1713785A1 (en) | 2003-12-17 | 2006-10-25 | Rib-X Pharmaceuticals, Inc. | Halogenated biaryl heterocyclic compounds and methods of making and using the same |
| KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| TW200534879A (en) * | 2004-03-25 | 2005-11-01 | Bristol Myers Squibb Co | Coated tablet formulation and method |
| AU2006242535B2 (en) * | 2005-04-29 | 2012-08-09 | Merck Sharp & Dohme Corp. | Therapeutic compositions |
| JP5426165B2 (ja) * | 2005-07-28 | 2014-02-26 | アイエスピー インヴェストメンツ インコーポレイテッド | 優れた生物学的利用能のベンゾキノン類 |
| EP1909762A2 (en) | 2005-07-28 | 2008-04-16 | Isp Investments Inc. | Amorphous efavirenz and the production thereof |
| US20070104785A1 (en) * | 2005-07-29 | 2007-05-10 | Navale Suryakant V | Tablets of linezolid form iii and processes for their preparation |
| EP1983966B1 (en) * | 2006-02-09 | 2013-06-26 | Merck Sharp & Dohme Corp. | Polymer formulations of cetp inhibitors |
| TW200815033A (en) * | 2006-08-10 | 2008-04-01 | Cipla Ltd | Antiretroviral solid oral composition |
| MX337145B (es) * | 2009-10-13 | 2016-02-15 | Melinta Therapeutics Inc | Composiciones farmaceuticas. |
| CN103153343B (zh) * | 2010-06-14 | 2015-02-11 | 陶氏环球技术有限责任公司 | 具有提高的醋酸酯和琥珀酸酯取代的醋酸羟丙基甲基纤维素琥珀酸酯 |
| CN103379917B (zh) | 2010-11-01 | 2016-10-12 | 梅琳塔治疗公司 | 药物组合物 |
-
2011
- 2011-11-21 PT PT118431907T patent/PT2642996T/pt unknown
- 2011-11-21 SG SG2013038971A patent/SG190354A1/en unknown
- 2011-11-21 EP EP11843190.7A patent/EP2642996B1/en active Active
- 2011-11-21 CN CN201180065667.4A patent/CN103391778B/zh not_active Expired - Fee Related
- 2011-11-21 MY MYPI2017000871A patent/MY182136A/en unknown
- 2011-11-21 JP JP2013540991A patent/JP6370550B2/ja active Active
- 2011-11-21 MY MYPI2013001885A patent/MY171941A/en unknown
- 2011-11-21 KR KR1020137013466A patent/KR101944124B1/ko active IP Right Grant
- 2011-11-21 ES ES11843190T patent/ES2836809T3/es active Active
- 2011-11-21 US US13/988,908 patent/US20140088164A1/en not_active Abandoned
- 2011-11-21 SG SG10201509530YA patent/SG10201509530YA/en unknown
- 2011-11-21 MX MX2013005813A patent/MX350565B/es active IP Right Grant
- 2011-11-21 EA EA201390764A patent/EA027791B1/ru not_active IP Right Cessation
- 2011-11-21 HU HUE11843190A patent/HUE052801T2/hu unknown
- 2011-11-21 WO PCT/US2011/061643 patent/WO2012071324A2/en active Application Filing
- 2011-11-21 BR BR112013012833A patent/BR112013012833A8/pt not_active Application Discontinuation
- 2011-11-21 UA UAA201307892A patent/UA113722C2/uk unknown
- 2011-11-21 NZ NZ610638A patent/NZ610638A/en not_active IP Right Cessation
- 2011-11-21 CA CA2818249A patent/CA2818249C/en active Active
- 2011-11-21 AU AU2011332031A patent/AU2011332031B2/en not_active Ceased
-
2013
- 2013-05-16 IL IL226378A patent/IL226378A0/en unknown
- 2013-05-22 ZA ZA2013/03732A patent/ZA201303732B/en unknown
-
2016
- 2016-09-09 US US15/260,424 patent/US10300046B2/en active Active
- 2016-12-15 JP JP2016243035A patent/JP2017081950A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201700008B (it) | Composizione farmaceutica | |
| SMT201600350B (it) | Composizioni farmaceutiche | |
| DK3246018T3 (da) | Farmaceutisk sammensætning | |
| BR112014003052A2 (pt) | composições farmacêuticas | |
| DK2640893T4 (da) | Sammensætninger | |
| DK3284467T3 (da) | Nikotinholdige farmaceutiske sammensætninger | |
| SMT201700050B (it) | Composizioni anestetiche termogelificanti | |
| DK2694038T3 (da) | Farmaceutisk sammensætning | |
| BR112012031667A2 (pt) | composição | |
| DK2632493T3 (da) | Lægemiddelindgivelsessammensætninger | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| CO6930367A2 (es) | Composiciones farmaceúticas | |
| BRPI1012539A2 (pt) | composições farmacêuticas | |
| BR112012032683A2 (pt) | composição | |
| EE201300005A (et) | Ravimkoostis | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| GT201200303A (es) | Formulaciones farmacéuticas | |
| BR112012002105A2 (pt) | formulação farmacêutica | |
| DK2654736T3 (da) | Hidtil ukendt farmaceutisk sammensætning | |
| IT1394400B1 (it) | Composizioni farmaceutiche | |
| BR112012032980A2 (pt) | composição | |
| CO6801722A2 (es) | Composiciones farmacéuticas | |
| BR112013008074A2 (pt) | combinações farmacêuticas | |
| SMT201500005B (it) | Composizione framaceutica inalabile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: MELINTA THERAPEUTICS, INC. (US) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B25D | Requested change of name of applicant approved |
Owner name: MELINTA SUBSIDIARY, CORP. (US) |
|
| B25K | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication |
Owner name: MELINTA SUBSIDIARY CORP. (US) Free format text: RETIFICACAO DO DESPACHO ?(25.4) ? ALTERACAO DE NOME? PUBLICADO NA RPI NO 2507, DE22/01/2019, QUANTO AO ITEM ?(71) - DEPOSITANTE?.ONDE SE LE: ?MELINTA SUBSIDIARY, CORP.?LEIA-SE: ?MELINTA SUBSIDIARY CORP.? |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |